Intrinsic Value of S&P & Nasdaq Contact Us

Absci Corporation ABSI NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.16
+94.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Absci Corporation (ABSI) has a negative trailing P/E of -3.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 39.6 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -25.71%, forward earnings yield 2.52%. PEG 0.06 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.06); analyst target implies upside (+94.3%).
  • Forward P/E 39.6 — analysts expect a return to profitability with estimated EPS of $0.08 for FY2029.
  • PEG Ratio 0.06 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -25.71% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 2.52% as earnings recover.
  • Analyst consensus target $6.16 (+94.3% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 40/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ABSI

Valuation Multiples
P/E (TTM)-3.9
Forward P/E39.6
PEG Ratio0.06
Forward PEG0.06
P/B Ratio2.37
P/S Ratio162.58
EV/EBITDA-3.9
Per Share Data
EPS (TTM)$-0.76
Forward EPS (Est.)$0.08
Book Value / Share$1.26
Revenue / Share$0.02
FCF / Share$-0.62
Yields & Fair Value
Earnings Yield-25.71%
Forward Earnings Yield2.52%
Dividend Yield0.00%
Analyst Target$6.16 (+94.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -302.5 0.00 -48.39 966.83 -
2020 -138.8 -0.22 29.72 416.67 -
2021 -7.5 -0.07 2.08 158.87 -
2022 -1.8 -0.50 0.70 33.20 -
2023 -3.5 -0.80 2.19 67.60 -
2024 -2.8 0.13 1.61 63.70 -
2025 -4.1 0.39 2.52 170.48 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.07 $2.06M $-6.8M -330.1%
2020 $-0.16 $4.78M $-14.57M -304.8%
2021 $-1.09 $4.78M $-100.96M -2111.3%
2022 $-1.15 $5.75M $-104.9M -1825.4%
2023 $-1.20 $5.72M $-110.57M -1933.6%
2024 $-0.94 $4.53M $-103.11M -2274.1%
2025 $-0.84 $2.8M $-115.18M -4113.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.78 $-1.06 – $-0.51 $9.67M $2.73M – $29.45M 6
2027 $-0.78 $-1.23 – $-0.43 $36.35M $3.42M – $124M 6
2028 $-0.29 $-0.51 – $0.08 $84.84M $11.39M – $276.46M 4
2029 $0.08 $-0.01 – $0.31 $134.75M $18.09M – $439.09M 2
2030 $0.61 $-0.08 – $2.40 $189.44M $25.44M – $617.29M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message